Profile data is unavailable for this security.
About the company
Blis Technologies Limited is a New Zealand-based manufacturer of advanced probiotic strains. The Company’s principal activity is developing healthcare products based on strains of bacteria that produce bacteriocin activity for sale in New Zealand and overseas. It delivers probiotic solutions for specific health targets, including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. Its probiotic portfolio includes BLIS K12, BLIS M18 and BLIS Q24. It sells ingredients and finishes goods to manufacturers and wholesale customers. The BLIS K12 (Streptococcus salivarius K12) is a probiotic to support the mouth and throat. The BLIS M18 (Streptococcus salivarius M18) is a probiotic to support teeth and gum health. The BLIS Q24 balances and restores the skin microbiome, restoring its natural health, clarity and radiance. The Company’s products are sold throughout New Zealand and in Australia, Asia, Europe and the United States.
- Revenue in NZD (TTM)11.53m
- Net income in NZD646.00k
- Incorporated2000
- Employees10.00
- LocationBLIS Technologies Ltd81 Glasgow StreetDUNEDIN 9012New ZealandNZL
- Phone+64 34740988
- Fax+64 34749050
- Websitehttps://blis.co.nz/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Immuron Ltd | 3.85m | -4.18m | 22.10m | 6.00 | -- | 1.17 | -- | 5.74 | -0.017 | -0.017 | 0.0157 | 0.0769 | 0.1664 | 0.6468 | 7.92 | 596,106.70 | -18.06 | -27.48 | -19.86 | -29.58 | 80.87 | 77.52 | -108.52 | -296.64 | 7.79 | -2.85 | 0.0023 | -- | 135.85 | -13.34 | -32.66 | -- | 3.27 | -- |
| Sotac Pharmaceuticals Ltd | 11.36m | 880.59k | 22.32m | 89.00 | 18.48 | 7.20 | 18.61 | 1.96 | 5.58 | 5.58 | 60.69 | 14.31 | -- | -- | -- | -- | -- | -- | -- | -- | 30.90 | -- | 7.75 | -- | 0.9968 | 8.62 | 0.4806 | -- | -20.74 | -- | 56.17 | -- | -- | -- |
| BLIS Technologies Ltd | 11.53m | 646.00k | 23.03m | 10.00 | 30.51 | 2.00 | 19.61 | 2.00 | 0.0006 | 0.0006 | 0.0091 | 0.009 | 0.8955 | -- | 8.41 | -- | 5.02 | -2.45 | 5.64 | -2.90 | -- | -- | 5.60 | -2.40 | 8.30 | 23.45 | 0.0328 | -- | 12.61 | 6.52 | 147.85 | 11.14 | 34.35 | -- |
| China Health Group Inc | 4.85m | -13.16m | 23.35m | 42.00 | -- | 1.22 | -- | 4.82 | -0.0631 | -0.0631 | 0.0232 | 0.092 | 0.1438 | -- | 0.246 | 550,797.60 | -39.07 | 6.84 | -51.26 | 9.52 | 38.33 | 74.98 | -271.70 | 19.19 | -- | -- | 0.00 | 0.00 | 63.67 | -18.51 | -267.82 | -- | 30.37 | -- |
| Cann Group Ltd | 17.71m | -31.54m | 23.56m | 40.00 | -- | 0.4306 | -- | 1.33 | -0.0724 | -0.0724 | 0.0406 | 0.1161 | 0.1237 | 0.3952 | 7.37 | -- | -22.03 | -22.28 | -34.23 | -24.43 | 21.11 | -- | -178.07 | -407.57 | 0.0861 | -5.88 | 0.5646 | -- | 114.90 | 89.76 | -27.66 | -- | -11.16 | -- |
| Aarey Drugs and Pharmaceuticals Ltd | 68.20m | 826.41k | 24.67m | 0.00 | 27.01 | -- | 22.03 | 0.3618 | 1.66 | 1.66 | 137.72 | -- | -- | -- | -- | -- | -- | 2.78 | -- | 5.84 | 4.17 | 3.66 | 1.21 | 1.52 | -- | 1.63 | -- | -- | -14.96 | 3.70 | -42.38 | -9.40 | 10.95 | -- |
